Multiple COVID-19 variants are circulating around the world and becoming more common. These mutations can alter the ability of the virus to take hold and replicate within our cells.
Academic rigor, journalistic flair
Articles on COVID-19
Displaying 3581 - 3600 of 7973 articles
Cancelling the Tokyo games would be yet another blemish for the new government and could doom its chances in the next election later this year.
We’ve gone from a novel virus to several COVID-19 vaccines in less than a year. Here’s what we’ve learned from earlier vaccines to allow this to happen.
Some young people feel their voices and experiences during the pandemic have not been heard.
A virus that is 30% more transmissible is more deadly than a virus that is 30% more deadly. Counter-intuitive but true.
When a pandemic hits, questions that immediately arise include what impact there will be on public health, the economy and other aspects of society. Another set of questions involves response priorities…
Vaccines that use harmless viruses as a delivery mechanism are vulnerable to being attacked by our immune system – but experimenting with how they are given could get around this.
History tells us that mass vaccination campaigns are usually messy, while elsewhere, lower-income countries are turning to China, Russia and India for vaccines.
With a rising stock market and a booming economy in some industries, not all Americans have been negatively impacted by Covid-19. Which parts of the population have come out on top?
During the first lockdown, the number of people seeking help for depression, anxiety and self-harm dropped by up to 48% in some cases.
In the face of stricter rules, the police and government need to clarify messaging around sanctions
Rate rises appear to be coming back into fashion amid speculation that Rishi Sunak and the Biden administration are changing tack.
Stay-at-home measures allowed many people to slow down, reflect and invest more time in themselves.
CC BY-NC-ND13.3 MB (download)
Nigeria needs a coherent plan to get COVID-19 vaccines.
If South Africa is serious about being able to supply anti-pandemic vaccines in future, it needs to rethink the scale of financial, technical and strategic investment into vaccine production.
Since 1953, the economy has only rarely been in recession when a Democrat was in the White House.
History tells us that delays, administrative hurdles, messiness and complexity are the norm.
We are still only beginning to understand the psychological effects that pandemic restrictions are having on us.
As the eradication of polio and the successful rollout of AIDS treatments have shown in the past, global cooperation in the face of COVID-19 is possible.
New data shows how unhappy and polarised America has become – due largely to COVID-19.
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Bioethics, University of Portsmouth
